Digital therapeutic (DTx) is commonly called as software for drugs and which deliver evidence based therapeutic interventions to patients that are driven by high quality software program to manage, prevent, or treat broad spectrum of mental, physical, and behavioral conditions. This is from an independent category of evidence based products within the broader healthcare landscape.
Increase in incidences of preventable chronic diseases considered as key driving factor which is expected to boost the global digital therapeutic (DTx) market growth. Furthermore, rise in emphasis on preventive healthcare will have the positive impact on market growth. Moreover, increase in number of venture capitalists that are investing in the market will fuel the market growth. In addition to that, increase in internet usage as well as dependency on smartphones, digital therapeutics (DTx) provide easy tracking and monitoring of patients and their vital stats without invention expected to propel the market growth during this forecast period.
However, data safety and security is the major restraining factor which expected to hamper the global digital therapeutic (DTx) market growth. Also, lack of awareness and access to digital therapeutics programs in developing countries, and reluctance among patients to adopt digital therapeutics are some challenging factor which are expected to hinder the market growth.
Global Digital Therapeutic (DTx) Market is segmented into application such as Diabetes, CVD, Obesity, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others. Further, market is segmented into end Use such as Patients, Providers, Payers, Employers, and Others.
Also, Global Digital Therapeutic (DTx) Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in this report such as PROTEUS DIGITAL HEALTH, OMADA HEALTH, LIVONGO HEALTH, NOOM, WELLDOC, GINGER, PROPELLER HEALTH, 2MORROW, CANARY HEALTH, and MANGO HEALTH INC
By Application Diabetes CVD Obesity CNS Disease Respiratory Diseases Smoking Cessation Others By End Use Patients Providers Payers Employers Others
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Digital Therapeutic (DTx) Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Digital Therapeutic (DTx) Market, By Application
5.1 Y-o-Y Growth Comparison, By Application
5.2 Global Digital Therapeutic (DTx) Market Share Analysis, By Application
5.3 Global Digital Therapeutic (DTx) Market Size and Forecast, By Application
5.3.1 Diabetes
5.3.2 CVD
5.3.3. Obesity
5.3.4. CNS Diseases
5.3.5. Respiratory Diseases
5.3.6. Smoking Cessation
5.3.7. Others
6 Global Digital Therapeutic (DTx) Market, By End Use
6.1 Y-o-Y Growth Comparison, By End Use
6.2 Global Digital Therapeutic (DTx) Market Share Analysis, By End Use
6.3 Global Digital Therapeutic (DTx) Market Size and Forecast, By End Use
6.3.1 Patients
6.3.2 Providers
6.3.3 Payers
6.3.4 Employers
6.3.5Others
7Global Digital Therapeutic (DTx) Market, By Region
7.1 Global Digital Therapeutic (DTx) Market Share Analysis, By Region
7.2 Global Digital Therapeutic (DTx) Market Share Analysis, By Region
7.3 Global Digital Therapeutic (DTx) Market Size and Forecast, By Region
8North America Digital Therapeutic (DTx) Market Analysis and Forecast (2019 – 2030)
8.1 Introduction
8.2 North America Digital Therapeutic (DTx) Market Share Analysis, By Application
8.3 North America Digital Therapeutic (DTx) Market Size and Forecast, By End Use
8.4 North America Digital Therapeutic (DTx) Market Size and Forecast, By Country
8.4.1 U.S
8.4.2 Canada
8.4.3 Mexico
9Europe Digital Therapeutic (DTx) Market Analysis and Forecast (2019 – 2030)
9.1 Introduction
9.2 Europe Digital Therapeutic (DTx) Market Share Analysis, By Application
9.3 Europe Digital Therapeutic (DTx) Market Size and Forecast, By End Use
9.4 Europe Digital Therapeutic (DTx) Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10Asia Pacific Digital Therapeutic (DTx) Market Analysis and Forecast (2019 – 2030)
10.1 Introduction
10.2 Asia Pacific Digital Therapeutic (DTx) Market Share Analysis, By Application
10.3 Asia Pacific Digital Therapeutic (DTx) Market Size and Forecast, By End Use
10.4 Asia Pacific Digital Therapeutic (DTx) Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11Latin America Digital Therapeutic (DTx) Market Analysis and Forecast (2019 – 2030)
11.1 Introduction
11.2 Latin America Digital Therapeutic (DTx) Market Share Analysis, By Application
11.3 Latin America Digital Therapeutic (DTx) Market Size and Forecast, By End Use
11.4 Latin America Digital Therapeutic (DTx) Market Size and Forecast, By Country
12Middle East Digital Therapeutic (DTx) Market Analysis and Forecast (2019 – 2030)
12.1 Introduction
12.2 Middle East Digital Therapeutic (DTx) Market Share Analysis, By Application
12.3 Middle East Digital Therapeutic (DTx) Market Size and Forecast, By End Use
12.4 Middle East Digital Therapeutic (DTx) Market Size and Forecast, By Country
13Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14Company Profiles
14.1 PROTEUS DIGITAL HEALTH
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 OMADA HEALTH
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 LIVONGO HEALTH
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 NOOM
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 WELLDOC
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 GINGER
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 PROPELLER HEALTH
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 2MORROW
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 CANARY HEALTH
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
14.10 MANGO HEALTH INC
14.10.1 Overview
14.10.2 Offerings
14.10.3 Key Financials
14.10.4 Business Segment & Geographic Overview
14.10.5 Key Market Developments
14.10.6 Key Strategies
